122 related articles for article (PubMed ID: 1828519)
1. Antidepressant-like effects of buspirone mediated by the 5-HT1A post-synaptic receptors in the learned helplessness paradigm.
Martin P; Tissier MH; Adrien J; Puech AJ
Life Sci; 1991; 48(26):2505-11. PubMed ID: 1828519
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism.
Martin P; Beninger RJ; Hamon M; Puech AJ
Behav Brain Res; 1990 May; 38(2):135-44. PubMed ID: 2141988
[TBL] [Abstract][Full Text] [Related]
3. 1-(2-pyrimidinyl)-piperazine may alter the effects of the 5-HT1A agonist in the learned helplessness paradigm in rats.
Martin P
Psychopharmacology (Berl); 1991; 104(2):275-8. PubMed ID: 1678895
[TBL] [Abstract][Full Text] [Related]
4. Reversal of helpless behavior in rats by putative 5-HT1A agonists.
Giral P; Martin P; Soubrié P; Simon P
Biol Psychiatry; 1988 Feb; 23(3):237-42. PubMed ID: 2892540
[TBL] [Abstract][Full Text] [Related]
5. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action.
Kennett GA; Marcou M; Dourish CT; Curzon G
Eur J Pharmacol; 1987 Jun; 138(1):53-60. PubMed ID: 2442002
[TBL] [Abstract][Full Text] [Related]
6. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Tricklebank MD; Neill J; Kidd EJ; Fozard JR
Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
[TBL] [Abstract][Full Text] [Related]
7. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
8. 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis.
Cervo L; Grignaschi G; Samanin R
Eur J Pharmacol; 1988 Dec; 158(1-2):53-9. PubMed ID: 2975608
[TBL] [Abstract][Full Text] [Related]
9. 5-HT1A agonists and dopamine: the effects of 8-OH-DPAT and buspirone on brain-stimulation reward.
Montgomery AM; Rose IC; Herberg LJ
J Neural Transm Gen Sect; 1991; 83(1-2):139-48. PubMed ID: 1826841
[TBL] [Abstract][Full Text] [Related]
10. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
[TBL] [Abstract][Full Text] [Related]
11. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
12. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
Schreiber R; De Vry J
Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression.
Kennett GA; Dourish CT; Curzon G
Eur J Pharmacol; 1987 Feb; 134(3):265-74. PubMed ID: 2883013
[TBL] [Abstract][Full Text] [Related]
14. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT.
Gilbert F; Dourish CT
Psychopharmacology (Berl); 1987; 93(3):349-52. PubMed ID: 2893412
[TBL] [Abstract][Full Text] [Related]
15. Brainstem 5-hydroxytrytamine1A binding sites are not down-regulated by agonists which induce tolerance in the rat: myoclonus and other serotonergic behaviors.
Murthy JN; Pranzatelli MR
J Recept Res; 1992; 12(3):287-97. PubMed ID: 1387164
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced defaecation in rats: role of central 5-HT1A receptors.
Croci T; Landi M; Bianchetti A; Manara L
Br J Pharmacol; 1995 May; 115(1):203-9. PubMed ID: 7647978
[TBL] [Abstract][Full Text] [Related]
17. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome.
Smith LM; Peroutka SJ
Pharmacol Biochem Behav; 1986 Jun; 24(6):1513-9. PubMed ID: 2942947
[TBL] [Abstract][Full Text] [Related]
19. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine.
Blier P; Serrano A; Scatton B
Synapse; 1990; 5(2):120-33. PubMed ID: 2137943
[TBL] [Abstract][Full Text] [Related]
20. 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats.
Yocca FD; Wright RN; Margraf RR; Eison AS
Pharmacol Biochem Behav; 1990 Jan; 35(1):251-4. PubMed ID: 2138331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
